GlaxoSmithKline
Glaxo makes open offer to hike stake in Indian arm
26 Nov 2012
The company is offering Rs3,900 per share, a premium of approximately 28 per cent to the company's closing share price on the NSE on Friday
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 Jul 2012
US biopharmaceutical company Human Genome Sciences yesterday agreed to be acquired by GlaxoSmithKline Plc (GSK) for a sweetened $3 billion
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 Jul 2012
GlaxoSmithKline is close to acquiring Human Genome Sciences for about $2.8 billion, two months after it went hostile with its $2.59-billion bid for the US biopharmaceutical firm
GlaxoSmithKline to pay record $3 billion in US drug fraud case
03 Jul 2012
GlaxoSmithKline plc (GSK) will pay a record $3 billion to various health authorities in the US in the largest healthcare fraud settlement in US history
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 Jun 2012
No rival bids have emerged so far since GSK has invested $125 million in an ongoing research partnership with HGS and the two are collaborating on the development of three drugs
Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid
18 May 2012
HGS, which is GSK's partner on two drug developments, had rejected the UK firm's takeover offer saying that it was an opportunistic move
Aspen to buy GSK’s international OTC brands
20 Apr 2012
Patented drugs overpriced, admits Glaxo CEO Witty
28 Sep 2011
The industry has to strike a balance between delivering innovation and affordable pricing, particularly in emerging markets and least developed countries, says GSK chief executive Andrew Witty.
GlaxoSmithKline to take $3.4-bn legal charge for diabetes drug Avandia
18 Jan 2011
The £2.2-billion charge equates to an after-tax cost of £1.8 billion in GSK's fourth quarter of fiscal 2010.
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation